Your browser doesn't support javascript.
loading
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors.
Duca, Matteo; Lim, Darren Wan-Teck; Subbiah, Vivek; Takahashi, Shunji; Sarantopoulos, John; Varga, Andrea; D'Alessio, Joseph A; Abrams, Tinya; Sheng, Qing; Tan, Eugene Youchin; Rosa, Maria Santos; Gonzalez-Maffe, Juan; Sand-Dejmek, Janna; Fabre, Claire; Martin, Miguel.
Afiliación
  • Duca M; S.C. Oncologia Medica 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Lim DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Subbiah V; Division of Cancer Medicine & Division of Pediatrics, The University of MD Anderson Cancer Center, Houston, Texas.
  • Takahashi S; Department of Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Sarantopoulos J; Institute for Drug Development, Mays Cancer Center at University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, Texas.
  • Varga A; Drug Development Department, Institut de Cancérologie Gustave Roussy, Villejuif, France.
  • D'Alessio JA; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Abrams T; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Sheng Q; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Tan EY; Allorion Therapeutics, Natick, Massachusetts.
  • Rosa MS; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Gonzalez-Maffe J; Novartis Pharma AG, Basel, Switzerland.
  • Sand-Dejmek J; Novartis Pharma AG, Basel, Switzerland.
  • Fabre C; Novartis Pharma AG, Basel, Switzerland.
  • Martin M; Novartis Pharma AG, Basel, Switzerland.
Mol Cancer Ther ; 21(4): 625-634, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35131875
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Inmunoconjugados / Carcinoma de Células Escamosas de Esófago / Neoplasias de Cabeza y Cuello / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Inmunoconjugados / Carcinoma de Células Escamosas de Esófago / Neoplasias de Cabeza y Cuello / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article País de afiliación: Italia